Abstract
Encephalitis is the inflammation of the brain parenchyma. The most common signs and symptoms include fever, headache, vomiting, altered mental status, seizures, and focal neurologic deficits. Altered mental status is the main feature differentiating encephalitis from uncomplicated meningitis, which usually presents fever, headache, and nuchal rigidity. Since encephalitis is often accompanied by meningitis, the term meningoencephalitis is generally used interchangeably with encephalitis [1, 2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Glaser CA, Bloch KC. Encephalitis. In: Long SS, Prober CG, Fischer M, Kimberlin DW, editors. Principles and practice of pediatric infectious diseases. 6th ed. Philadelphia: Elsevier; 2023. p. 315–31.
Bronstein DE, Glaser CA. Encephalitis and meningoencephalitis. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 8th ed. Philadelphia: Elsevier; 2019. p. 361–76.
Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear. 2014;18:1–17.
Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57:1114–28.
Thomson J, Sucharew H, Cruz AT, et al. Cerebrospinal fluid reference values for young infants undergoing lumbar puncture. Pediatrics. 2018;141:e20173405.
Erkkinen MG, Berkowitz AL. Clinical approach to diagnosing encephalopathy. Am J Med. 2019;132:1142–7.
Toledano M, Davies NWS. Infectious encephalitis: mimics and chameleons. Pr Neurol. 2019;19:225–37.
Dorcet G, Benaiteau M, Bost C, et al. Two cases of late-onset anti-NMDAr auto-immune encephalitis after herpes simplex virus 1 encephalitis. Front Neurol. 2020;11:38.
Gelfand JM. Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis. Lancet Neurol. 2018;17:733–5.
Mielcarska MB, Bossowska-Nowicka M, Toka FN. Functional failure of TLR3 and its signaling components contribute to herpes simplex encephalitis. J Neuroimmunol. 2018;316:65–73.
Parpia AS, Li Y, Chen C, Dhar B, Crowcroft NS. Encephalitis, Ontario, Canada, 2002-2013. Emerg Infect Dis. 2016;22:426–32.
Valle DAD, Santos MLSF, Giamberardino HIG, Raboni SM, Scola RH. Acute childhood viral encephalitis in southern Brazil. Pediatr Infect Dis J. 2020;39:894–8.
Messacar K, Fischer M, Dominguez SR, Tyler KL, Abzug MJ. Encephalitis in US children. Infect Dis Clin N Am. 2018;32:145–62.
Britton PN, Dale RC, Blyth CC, et al. Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study. Clin Infect Dis. 2020;70:2517–26.
Erickson TA, Muscal E, Munoz FM, et al. Infectious and autoimmune causes of encephalitis in children. Pediatrics. 2020;145:e20192543.
Ai J, Xie Z, Liu G, et al. Etiology and prognosis of acute viral encephalitis and meningitis in Chinese children: a multicentre prospective study. BMC Infect Dis. 2017;17:494.
Mondal R, Ganguly U, Deb S, Shome G, Pramanik S, Bandyopadhyay D, Lahiri D. Meningoencephalitis associated with COVID-19: a systematic review. J Neurovirol. 2021;27:12–25.
Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268:3059–71.
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California encephalitis project. Clin Infect Dis. 2012;54:899–904.
Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83:166–77.
Ellul M, Solomon T. Acute encephalitis—diagnosis and management. Clin Med. 2018;18:155–9.
Daxboeck F, Blacky A, Seidl R, Krause R, Assadian O. Diagnosis, treatment, and prognosis of Mycoplasma pneumoniae childhood encephalitis: systematic review of 58 cases. J Child Neurol. 2004;19:865–71.
Wang CX. Assessment and management of acute disseminated encephalomyelitis (ADEM) in the pediatric patient. Paediatr Drugs. 2021;23:213–21.
Fowler Å, Ygberg S, Svensson E, Bergman K, Cooray G, Wickström R. Prospective evaluation of childhood encephalitis: predisposing factors, prevention and outcome. Pediatr Infect Dis J. 2020;39:e417–22.
Bagdure D, Custer JW, Rao S, et al. Hospitalized children with encephalitis in the United States: a pediatric health information system database study. Pediatr Neurol. 2016;61:58–62.
Hatachi T, Michihata N, Inata Y, et al. Prognostic factors among children with acute encephalitis/encephalopathy associated with viral and other pathogens. Clin Infect Dis. 2021;73:76–82.
Khandaker G, Jung J, Britton PN, King C, Yin JK, Jones CA. Long-term outcomes of infective encephalitis in children: a systematic review and meta-analysis. Dev Med Child Neurol. 2016;58:1108–15.
Rismanchi N, Gold JJ, Sattar S, et al. Neurological outcomes after presumed childhood encephalitis. Pediatr Neurol. 2015;53:200–6.
Pillai SC, Hacohen Y, Tantsis E, et al. Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome. Pediatrics. 2015;135:e974–84.
Pöyhönen H, Setänen S, Isaksson N, et al. Neurological and cognitive performance after childhood encephalitis. Front Pediatr. 2021;9:646684.
Chen T, Liu G. Long-term outcome of acute central nervous system infection in children. Pediatr Investig. 2018;2:155–63.
Djupesland G, Flottorp G, Degré M, Stien R, Skrede S. Cochlear hearing loss and viral infection. Acta Otolaryngol. 1979;87:247–54.
Megli CJ, Coyne CB. Infections at the maternal-fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20:67–82.
Anderson JL, Levy PT, Leonard KB, Smyser CD, Tychsen L, Cole FS. Congenital lymphocytic choriomeningitis virus: when to consider the diagnosis. J Child Neurol. 2014;29:837.
Mehrjardi MZ. Is Zika virus an emerging TORCH agent? An invited commentary. Virol Res Treat. 2017;8:1–3.
Van Maldergem L, Van Camp G, Deltenre P. Hearing impairment. In: Swaiman KF, Ashwal S, Ferriero DM, et al., editors. Swaiman’s pediatric neurology—principles and practice. 6th ed. Philadelphia: Elsevier; 2018. p. 305–22.
Davis NL, King CC, Kourtis AP. Cytomegalovirus infection in pregnancy. Birth Defects Res. 2017;109:336–46.
Ssentongo P, Hehnly C, Birungi P, et al. Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening. JAMA Netw Open. 2021;4:e2120736.
Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134:972–82.
Buca D, Di Mascio D, Rizzo G, et al. Outcome of fetuses with congenital cytomegalovirus infection and normal ultrasound at diagnosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57:551–9.
Chiopris G, Veronese P, Cusenza F, et al. Congenital cytomegalovirus infection: update on diagnosis and treatment. Microorganisms. 2020;8:1516.
Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41:57–62.
Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624–30.
Lanzieri TM, Chung W, Flores M, et al. Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics. 2017;139:e20162610.
Karimi-Boroujeni M, Zahedi-Amiri A, Coombs KM. Embryonic origins of virus-induced hearing loss: overview of molecular etiology. Viruses. 2021;13:71.
Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372:933–43.
Hughes BL, Clifton RG, Rouse DJ, et al. A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection. N Engl J Med. 2021;385:436.
Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med. 2014;370:1316.
Nagel A, Dimitrakopoulou E, Teig N, et al. Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay. PLoS One. 2020;15:e0227143.
Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307.
Yazigi A, De Pecoulas AE, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Picone O. Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med. 2017;30:274–8.
Parving A, Vejtorp M, Møller K, Møller JK. Congenital hearing loss and rubella infection. Acta Otolaryngol. 1980;90:262–6.
Paramita DV, Purnami N. Profile of congenital rubella syndrome in Soetomo General Hospital Surabaya, Indonesia. Infect Dis Rep. 2020;12:8718.
Tipayno MJC. A ten-year review of brainstem auditory evoked response testing at the Philippine Children’s Medical Center: patient demographics and outcomes. Philipp J Otolaryngol Head Neck Surg. 2008;23:17–22.
Rubella vaccines: WHO position paper. Jul 2020. https://apps.who.int/iris/bitstream/handle/10665/332952/WER9527-306-324-eng-fre.pdf?sequence=1&isAllowed=y. Accessed 17 Oct 2022.
World Health Organization. Vaccine-preventable diseases surveillance standards. Congenital rubella syndrome. Geneva: WHO; 2018. p. 1–16. Updated 5 Sep 2018. https://cdn.who.int/media/docs/default-source/immunization/vpd_surveillance/vpd-surveillance-standards-publication/who-surveillancevaccinepreventable-03-crs-r2.pdf?sfvrsn=7d83d274_8&download=true. Accessed 17 Oct 2022.
Dontigny L, Arsenault MY, Martel MJ. No. 203-Rubella in pregnancy. J Obstet Gynaecol Can. 2018;40:e615–21.
Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91:501–8.
Kota AS, Shabbir N. Congenital toxoplasmosis. In: StatPearls. Treasure Island, FL: StatPearls; 2022. 27 Jun 2022. https://www.ncbi.nlm.nih.gov/books/NBK545228/. Accessed 17 Oct 2022.
Maldonado YA, Read JS. Committee on infectious diseases. Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States. Pediatrics. 2017;139:e20163860.
Saleh MM, Al-Shamiri AH, Qaed AA. Seroprevalence and incidence of Toxoplasma gondii among apparently healthy and visually or hearing disabled children in Taiz City, Yemen. Korean J Parasitol. 2010;48:71–3.
Al Muhaimeed H. Prevalence of sensorineural hearing loss due to toxoplasmosis in Saudi children: a hospital-based study. Int J Pediatr Otorhinolaryngol. 1996;34:1–8.
Brown ED, Chau JK, Atashband S, Westerberg BD, Kozak FK. A systematic review of neonatal toxoplasmosis exposure and sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2009;73:707–11.
Salviz M, Montoya JG, Nadol JB, Santos F. Otopathology in congenital toxoplasmosis. Otol Neurotol. 2013;34:1165–9.
Paquet C, Yudin MH. No. 285-Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2018;40:e687–93.
Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31:e00057–17.
World Health Organization. Zika virus fact sheet. 20 Jul 2018. https://www.who.int/news-room/fact-sheets/detail/zika-virus. Accessed 17 Oct 2022.
European Centre for Disease Prevention and Control. Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain–Barré syndrome—6th update, 23 May 2016. Stockholm: ECDC; 2016. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-zika-virus-disease-epidemic-potential-association-4. Accessed 17 Oct 2022.
Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374:951–8.
Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr. 2017;171:288–95.
Leal MC, Muniz LF, Ferreira TS, et al. Hearing loss in infants with microcephaly and evidence of congenital Zika virus infection—Brazil, November 2015-May 2016. MMWR. 2016;65:917–9.
Centers for Disease Control and Prevention. Zika virus: prevention and transmission. Reviewed 20 Sep 2021. https://www.cdc.gov/zika/prevention/. Accessed 17 Oct 2022.
Venkatesan A, Murphy OC. Viral encephalitis. Neurol Clin. 2018;36:705–24.
Vilibic-Cavlek T, Savic V, Ferenc T, et al. Lymphocytic choriomeningitis-emerging trends of a neglected virus: a narrative review. Trop Med Infect Dis. 2021;6:88.
Peeling RW, Mabey D, Kamb ML, Chen X-S, Radolf JD, Benzaken AS. Syphilis. Nat Rev Dis Prim. 2017;3:17073.
Kwak J, Lamprecht C. A review of the guidelines for the evaluation and treatment of congenital syphilis. Pediatr Ann. 2015;44:e108–14.
Chau J, Atashband S, Chang E, Westerberg BD, Kozak FK. A systematic review of pediatric sensorineural hearing loss in congenital syphilis. Int J Pediatr Otorhinolaryngol. 2009;73:787–92.
Marra CM, Maxwell CL, Ramchandani M, et al. Hearing loss in individuals at risk for neurosyphilis. Int J STD AIDS. 2020;31:1178–85.
Brew BJ, Garber JY. Neurologic sequelae of primary HIV infection. Handb Clin Neurol. 2018;152:65–74.
Govender R, Eley B, Walker K, Petersen R, Wilmshurst JM. Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection. J Child Neurol. 2011;26:1355–64.
Buriti AK, Oliveira SH, Muniz LF. Hearing loss in children with HIV/AIDS. Codas. 2013;25:513–20.
Assuiti LF, Lanzoni GM, Santos FC, Erdmann AL, Meirelles BH. Hearing loss in people with HIV/AIDS and associated factors: an integrative review. Braz J Otorhinolaryngol. 2013;79:248–55.
Palacios GC, Montalvo MS, Fraire MI, Leon E, Alvarez MT, Solorzano F. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy. Int J Pediatr Otorhinolaryngol. 2008;72:1671–81.
Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, González PA. Herpes simplex virus evasion of early host antiviral responses. Front Cell Infect Microbiol. 2019;9:127.
Whitley R, Baines J. Clinical management of herpes simplex virus infections: past, present, and future. F1000Res. 2018;7:F1000 Faculty Rev-1726.
Stahl JP, Mailles A. Herpes simplex virus encephalitis update. Curr Opin Infect Dis. 2019;32:239–43.
Fraley CE, Pettersson DR, Nolt D. Encephalitis in previously healthy children. Pediatr Rev. 2021;42:68–77.
Armangue T, Spatola M, Vlagea A, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17:760–72.
Westerberg BD, Atashband S, Kozak FK. A systematic review of the incidence of sensorineural hearing loss in neonates exposed to Herpes simplex virus (HSV). Int J Pediatr Otorhinolaryngol. 2008;72:931–7.
Kaga K, Kaga M, Tamai F, Shindo M. Auditory agnosia in children after herpes encephalitis. Acta Otolaryngol. 2003;123:232–5.
Park SM, Han C, Lee JW, Kong TH, Seo YJ. Does Herpes virus reactivation affect prognosis in idiopathic sudden sensorineural hearing loss? Clin Exp Otorhinolaryngol. 2017;10:66–70.
al Muhaimeed H, Zakzouk SM. Hearing loss and herpes simplex. J Trop Pediatr. 1997;43:20–4.
Leung AK, Hon KL, Leong KF, Sergi CM. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018;24:512–20.
Patterson MC. Neurological complications of measles (rubeola). Curr Neurol Neurosci Rep. 2020;20:2.
McKenna MJ. Measles, mumps, and sensorineural hearing loss. Ann N Y Acad Sci. 1997;830:291–8.
Ferren M, Horvat B, Mathieu C. Measles encephalitis: towards new therapeutics. Viruses. 2019;11:1017.
Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371:932–44.
Ohfuji S, Takagi A, Nakano T, Kumihashi H, Kano M, Tanaka T. Mumps-related disease burden in Japan: analysis of JMDC health insurance reimbursement data for 2005-2017. J Epidemiol. 2021;31:464–70.
Garty BZ, Danon YL, Nitzan M. Hearing loss due to mumps. Arch Dis Child. 1988;63:105–6.
Kanra G, Kara A, Cengiz AB, Isik P, Ceyhan M, Ataş A. Mumps meningoencephalitis effect on hearing. Pediatr Infect Dis J. 2002;21:1167–9.
Hashimoto H, Fujioka M, Kinumaki H, Kinki Ambulatory Pediatrics Study Group. An office-based prospective study of deafness in mumps. Pediatr Infect Dis J. 2009;28:173–5.
Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10:609.
Nagel MA, Niemeyer CS, Bubak AN. Central nervous system infections produced by varicella zoster virus. Curr Opin Infect Dis. 2020;33:273–8.
Crouch AE, Andaloro C. Ramsay Hunt syndrome. In: StatPearls. Treasure Island, FL: StatPearls; 2021. Updated 1 May 2022. https://www.ncbi.nlm.nih.gov/books/NBK557409/. Accessed 17 Oct 2022.
Wayman DM, Pham HN, Byl FM, Adour KK. Audiological manifestations of Ramsay Hunt syndrome. J Laryngol Otol. 1990;104:104–8.
Sejvar JJ. West Nile virus infection. Microbiol Spectr. 2016;4:3.
Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol. 2004;61:1210–20.
Casetta I, Ciorba A, Cesnik E, Trevisi P, Tugnoli V, Bovo R. West Nile virus neuroinvasive disease presenting with acute flaccid paralysis and bilateral sensorineural hearing loss. J Neurol. 2011;258:1880–1.
Khalil A, Moutran H, Corr C, Elias F. A case of West Nile viral encephalitis with reversible hearing loss in an immunocompetent patient. Int J Infect Dis. 2016;53:155.
McBride W, Gill KR, Wiviott L. West Nile virus infection with hearing loss. J Infect. 2006;53:e203–5.
Weatherhead JE, Miller VE, Garcia MN, et al. Long-term neurological outcomes in West Nile virus-infected patients: an observational study. Am J Trop Med Hyg. 2015;92:1006–12.
Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016;2016:6803098.
Klein RS. Encephalitic arboviruses of Africa: emergence, clinical presentation and neuropathogenesis. Front Immunol. 2021;23(12):769942.
Paz-Bailey G, Adams L, Wong JM, et al. Dengue vaccine: recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recomm Rep. 2021;17(70):1–16.
Soni K, Bohra GK, Nair NP, Kaushal D, Patro SK, Goyal A. Sensorineural hearing loss in dengue: a pilot study. Iran J Otorhinolaryngol. 2021;33:57–161.
Okokhere PO, Erameh CO, Alikah F, et al. Acute Lassa virus encephalitis with Lassa virus in the cerebrospinal fluid but absent in the blood: a case report with a positive outcome. Case Rep Neurol. 2018;10:150–8.
Okokhere P, Colubri A, Azubike C, et al. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. Lancet Infect Dis. 2018;18:684–95.
Happi AN, Happi CT, Schoepp RJ. Lassa fever diagnostics: past, present, and future. Curr Opin Virol. 2019;37:132.
Williamson PR, Cho S, Nussenblatt V, et al. Neurologic manifestations of the World Health Organization’s list of pandemic and epidemic diseases. Front Neurol. 2021;12:634827.
World Health Organization. Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed 17 Oct 2022.
Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38:1549.e3.
Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: a note. Am J Otolaryngol. 2020;41:102473.
Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep. 2020;13:e238419.
Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol. 2020;41:102483.
Kilic O, Kalcioglu MT, Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-COV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis. 2020;97:208–11.
Fisher KM, Montrief T, Ramzy M, Koyfman A, Long B. Cryptococcal meningitis: a review for emergency clinicians. Intern Emerg Med. 2021;16:1031–42.
Ming DK, Harrison TS. Cryptococcal meningitis. Br J Hosp Med (Lond). 2017;78:C125–7.
Yuanjie Z, Jianghan C, Nan X, et al. Cryptococcal meningitis in immunocompetent children. Mycoses. 2012;55:168–71.
Wang HC, Chang WN, Lui CC, et al. The prognosis of hearing impairment complicating HIV-negative cryptococcal meningitis. Neurology. 2005;65:320–2.
King KA, Ansari G, Panackal AA, et al. Audiologic and otologic complications of cryptococcal meningoencephalitis in non-HIV previously healthy patients. Otol Neurotol. 2019;40:e657–64.
Dalmau J, Porta-Etessam J. Síndromes paraneoplásicos cerebrales con manifestación otoneuroftalmológica [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations]. Rev Neurol. 2000;31:1213–9.
Souza PV, Bortholin T, Pinto WB, Santos AJ. Progressive hearing loss and cerebellar ataxia in anti-Ma2-associated autoimmune encephalitis. Arq Neuropsiquiatr. 2017;75:74–5.
Cheng H, Yang F, Zhang J, et al. Case report: anti-NMDA receptor encephalitis with bilateral hearing loss as the initial symptom. Front Neurol. 2021;12:648911.
Dubey D, Wilson MR, Clarkson B, et al. Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis. JAMA Neurol. 2020;77:1420–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Maraş Genç, H., Kara, B., Arısoy, E.S., Dutta, A. (2023). Meningoencephalitis in Children and Hearing Loss. In: Arısoy, A.E., Arısoy, E.S., Bayar Muluk, N., Cingi, C., Correa, A.G. (eds) Hearing Loss in Congenital, Neonatal and Childhood Infections. Comprehensive ENT. Springer, Cham. https://doi.org/10.1007/978-3-031-38495-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-031-38495-0_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-38494-3
Online ISBN: 978-3-031-38495-0
eBook Packages: MedicineMedicine (R0)